IMARC Group, a leading market research company, has recently releases report titled “Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.” The study provides a detailed analysis of the industry, including the global atrial fibrillation treatment market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the atrial fibrillation treatment market?
The global atrial fibrillation treatment market size reached US$ 6.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2027, exhibiting a growth rate (CAGR) of 11.93% during 2022-2027.
What is atrial fibrillation treatment?
Atrial fibrillation treatment represents medicines and surgeries used to treat patients suffering from irregular and rapid heart rates that enhance the risks of heart failure and stroke. They are of several types, such as maze surgery, catheter ablation, electric cardioversion, anticoagulants, anti-arrhythmics, etc. These categories of atrial fibrillation treatment effectively control heart rate, aid in restoring normal heart rhythm, and prevent cardiovascular complications. Consequently, they find extensive applications across numerous segments of the healthcare sector, including hospitals, cardiac labs, ambulatory surgical centers, etc.
What are the growth prospects and trends in the atrial fibrillation treatment industry?
The expanding geriatric population across the globe that is more prone to the risks of cardiovascular diseases (CVDs) is primarily driving the atrial fibrillation treatment market. Additionally, the shifting preferences toward minimally invasive (MI) surgical procedures are acting as significant growth-inducing factors. Besides this, the inflating investments undertaken by government bodies, especially in developing countries, to improve healthcare infrastructure and the escalating research and development (R&D) activities in the field of medical science are also positively influencing the market growth. Moreover, the launch of technologically advanced catheter ablation devices that can remove damaged heart tissues and the introduction of innovative mapping and recording systems are projected to fuel the atrial fibrillation treatment market over the forecasted period.
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- Atricure Inc.
- Biotronik
- Boston Scientific Corporation
- Cardiofocus Inc.
- Hansen Medical Inc
- Auris Health
- Johnson & Johnson
- Siemens Healthineers
- Stereotaxis Inc., etc.
What is included in market segmentation?
The report has segmented the market into the following categories:
- Breakup by Disorder Type:
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
- Permanent Atrial Fibrillation
- Others
- Breakup by Treatment Type:
- Medical Procedures
- Surgical Procedures
- Maze Surgery
- Catheter Ablation
- Non-Surgical Procedures
- Electric Cardioversion
- Diagnostic Catheters
- Mapping and Recording Systems
- Cardiac Monitors
- Access Devices
- Left Atrial Appendage and Closure Devices
- Intracardiac Echocardiography (ICE) Systems
- Medication
- Anticoagulants
- Anti-Arrhythmics
- Breakup by End-User:
- Hospitals
- Cardiac Labs
- Ambulatory Surgical Centers
- Others
- Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/atrial-fibrillation-treatment-market/requestsample
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany
